Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) regarding definition, diagnosis, bias, standard operating procedures (SOPs) and telehealth is intended to provide clinicians an overview of obesity medicine and provide basic organizational tools towards establishing, directing, managing, and maintaining an obesity medical practice. This CPS is based upon published scientific citations, clinical perspectives of OMA authors, and peer review by Obesity Medicine Association leadership. OMA has defined obesity as: “A chronic, progressive, relapsing, and treatable multi-factorial, neurobehavioral disease, wherein an increase in body fat promotes adipose tissue dysfunction and abnormal fat mass physical forces, resulting in adverse metabolic, biomechanical, and psychosocial health consequences.” While body mass index may be sufficiently diagnostic for populations and many patients, accurate diagnosis of adiposity in an individual may require anthropometric assessments beyond body weight alone (e.g., waist circumference, percent body fat, and android/visceral fat). Obesity complications can be categorized as “sick fat disease” (adiposopathy) and/or “fat mass disease.” Obesity complications predominantly of fat mass origins include sleep apnea and orthopedic conditions. Obesity complications due to adiposopathic endocrinopathies and/or immunopathies include cardiovascular disease, cancer, elevated blood sugar, elevated blood pressure, dyslipidemia, fatty liver, and alterations in sex hormones in both males (i.e., hypogonadism) and females (i.e., polycystic ovary syndrome). Obesity treatment begins with proactive steps to avoid weight bias, including patient-appropriate language, office equipment, and supplies. To help manage obesity and its complications, this CPS provides a practical template for an obesity medicine practice, creation of standard operating procedures, and incorporation of the OMA “ADAPT” method in telehealth (Assessment, Diagnosis, Advice, Prognosis, and Treatment). The OMA CPS regarding “Obesity Definition, Diagnosis, Bias, Standard Operating Procedures (SOPs), and Telehealth” is one in a series of OMA CPSs designed to assist clinicians care for patients with the disease of obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
Body Fatness and Cancer — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.003 · Cited by 2,691
Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity
Ward, Z. J., Bleich, S. N., Cradock, A. L., Barrett, J. L., Giles, C. M., Flax, C., Long, M. W., & Gortmaker, S. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmsa1909301 · Cited by 2,009 · cited 1×
“2 ] [34].”
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Ross, R., Neeland, I. J., Yamashita, S., Shai, I., Seidell, J., Magni, P., Santos, R. D., Arsenault, B., Cuevas, A., Hu, F. B., et al. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0310-7 · Cited by 1,966 · cited 3×
“Prognostically, waist circumference, visceral fat, and android fat better correlate to cardiometabolic disease than BMI or percent body fat [53].”
BackgroundInfluentialBray, G. A., Kim, K. K., Wilding, J. P. H., & on behalf of the World Obesity Federation (2017) · Obesity Reviews · doi:10.1111/obr.12551 · Cited by 1,612
Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016) · Human Reproduction · doi:10.1093/humrep/dew218 · Cited by 1,526
Impact of weight bias and stigma on quality of care and outcomes for patients with obesity
Phelan, S. M., Burgess, D. J., Yeazel, M. W., Hellerstedt, W. L., Griffin, J. M., & van Ryn, M. (2015) · Obesity Reviews · doi:10.1111/obr.12266 · Cited by 1,361
Neeland, I. J., Poirier, P., & Després, J.-P. (2018) · Circulation · doi:10.1161/circulationaha.117.029617 · Cited by 881 · cited 1×
“” Some individuals (especially females) may have higher percent body fat with limited (and sometimes negligible) visceral fat [54,55].”
BackgroundBrickwood, K.-J., Watson, G., O'Brien, J., & Williams, A. D. (2019) · JMIR mHealth and uHealth · doi:10.2196/11819 · Cited by 689
Nagappa, M., Liao, P., Wong, J., Auckley, D., Ramachandran, S. K., Memtsoudis, S., Mokhlesi, B., & Chung, F. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143697 · Cited by 684
Chiu, H.-Y., Chen, P.-Y., Chuang, L.-P., Chen, N.-H., Tu, Y.-K., Hsieh, Y.-J., Wang, Y.-C., & Guilleminault, C. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.10.004 · Cited by 650
Jakicic, J. M., Davis, K. K., Rogers, R. J., King, W. C., Marcus, M. D., Helsel, D., Rickman, A. D., Wahed, A. S., & Belle, S. H. (2016) · JAMA · doi:10.1001/jama.2016.12858 · Cited by 621 · cited 1×
“…[24]; nutrition and physical activity environment; type of behavior modi fi cation [25]; utilization of motivational interviewing; use of “ apps, ” text messages, and social media [25,26]; use of wearable technologies [27 – 31]; and treatment via anti-obesity medications and bariatric surgery.”
BackgroundMechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.025 · Cited by 608
Mental Health Conditions Among Patients Seeking and Undergoing Bariatric Surgery: A Meta-analysis
Dawes, A. J., Maggard-Gibbons, M., Maher, A. R., Booth, M. J., Miake-Lye, I., Beroes, J. M., & Shekelle, P. G. (2016) · JAMA · doi:10.1001/jama.2015.18118 · Cited by 579
The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis
Lim, S. S., Norman, R. J., Davies, M. J., & Moran, L. J. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01053.x · Cited by 539
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0406 · Cited by 510
BMI Cut Points to Identify At-Risk Asian Americans for Type 2 Diabetes Screening
Hsu, W. C., Araneta, M. R. G., Kanaya, A. M., Chiang, J. L., & Fujimoto, W. (2015) · Diabetes Care · doi:10.2337/dc14-2391 · Cited by 500 · cited 1×
“Total body fat is widely variable and correlates to body weight, height, and sex [48,49,51,52] Visceral and/or android fat directly correlate to adiposopathic metabolic diseases (e.g., diabetes mellitus, hypertension, dyslipidemia, cardiovascular disease, and cancer), perhaps more so than waist…”
BackgroundMa, C., Avenell, A., Bolland, M., Hudson, J., Stewart, F., Robertson, C., Sharma, P., Fraser, C., & MacLennan, G. (2017) · BMJ · doi:10.1136/bmj.j4849 · Cited by 464
Obesity as a Disease: The Obesity Society 2018 Position Statement
Jastreboff, A. M., Kotz, C. M., Kahan, S., Kelly, A. S., & Heymsfield, S. B. (2019) · Obesity · doi:10.1002/oby.22378 · Cited by 457 · cited 1×
“” Instead, obesity is a disease when [3,21]: The patient has excessive body fat as assessed by reliable measures.”
BackgroundBays, H. E. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.038 · Cited by 431 · cited 4×
“Pathogenic genetic effects promoted by both obesity and aging include telomere attrition, epigenetic alterations, stem cell exhaustion, and genomic instability [43,45].”
BackgroundInfluentialSelf-citationInsufficient Sleep Undermines Dietary Efforts to Reduce Adiposity
Nedeltcheva, A. V., Kilkus, J. M., Imperial, J., Schoeller, D. A., & Penev, P. D. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-7-201010050-00006 · Cited by 397 · cited 1×
“Sleep disorders and obesity are related, and an altered circadian system can lead to altered feeding (which may promote obesity), unhealthy effects on body composition, hyperglycemia, high blood pressure, dyslipidemia, and an increased risk of heart disease and stroke [98 – 101].”
BackgroundPadwal, R. S., Pajewski, N. M., Allison, D. B., & Sharma, A. M. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110387 · Cited by 392 · cited 1×
“The EOSS is a fi ve-stage obesity classi fi cation system that incorporates metabolic, physical, and psychological parameters [74].”
BackgroundOsteoarthritis, obesity and weight loss: evidence, hypotheses and horizons - a scoping review
Bliddal, H., Leeds, A. R., & Christensen, R. (2014) · Obesity Reviews · doi:10.1111/obr.12173 · Cited by 380
Committee Opinion No. 549: Obesity in Pregnancy
(2013) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000425667.10377.60 · Cited by 372
Song, Z., & Baicker, K. (2019) · JAMA · doi:10.1001/jama.2019.3307 · Cited by 371
Frühbeck, G., Busetto, L., Dicker, D., Yumuk, V., Goossens, G. H., Hebebrand, J., Halford, J. G. C., Farpour-Lambert, N. J., Blaak, E. E., Woodward, E., et al. (2019) · Obesity Facts · doi:10.1159/000497124 · Cited by 311 · cited 1×
“…ultimately help improve the International Classi fi cation of Diseases, based upon three dimensions: etiology, degree of obesity, and health risks [46]. a Patients may also be diagnosed if they donot meet the de fi ning levels but are receiving drug treatment for these diagnostic criteria. based…”
BackgroundMotivating or stigmatizing? Public perceptions of weight-related language used by health providers
Puhl, R., Peterson, J. L., & Luedicke, J. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.110 · Cited by 304 · cited 3×
“Pre-obesity Body mass index Excessive energy stores Affected by obesity Terms discouraged and best avoided include [37,39]: Morbidly obese Obese Fat Heavy Large size”
BackgroundThe pathogenesis and treatment of polycystic ovary syndrome: What’s new?
Bednarska, S., & Siejka, A. (2017) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/59380 · Cited by 284
Obesity May Accelerate the Aging Process
Salvestrini, V., Sell, C., & Lorenzini, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00266 · Cited by 260 · cited 3×
“Pathogenic genetic effects promoted by both obesity and aging include telomere attrition, epigenetic alterations, stem cell exhaustion, and genomic instability [43,45].”
BackgroundCurrent and investigational antiobesity agents and obesity therapeutic treatment targets
Bays, H. E. (2004) · Obesity Research · doi:10.1038/oby.2004.151 · Cited by 228 · cited 1×
“Cancer [80] Obesity increases the risk of cancer of the biliary tract, bladder, brain (i.e., meningiomas), breast (i.e., postmenopausal), cervix, colon/rectum, endometrium/uterus, ovary, esophagus, gallbladder, head and neck, kidney, leukemia, multiple myeloma, non-Hodgkin lymphoma, liver,…”
BackgroundSelf-citationShin, D., & Song, W. O. (2015) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2014.964675 · Cited by 200
Recent advances in the understanding and management of polycystic ovary syndrome
Rocha, A. L., Oliveira, F. R., Azevedo, R. C., Silva, V. A., Peres, T. M., Candido, A. L., Gomes, K. B., & Reis, F. M. (2019) · F1000Research · doi:10.12688/f1000research.15318.1 · Cited by 142 · cited 2×
“(cid:1) PCOS is a risk factor for [115,118]:”
BackgroundEffect of weight change on natural history of pelvic organ prolapse
Kudish, B. I., Iglesia, C. B., Sokol, R. J., Cochrane, B., Richter, H. E., Larson, J., Hendrix, S. L., & Howard, B. V. (2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318190a0dd · Cited by 140
Woolcott, O. O., & Bergman, R. N. (2020) · International Journal of Obesity · doi:10.1038/s41366-019-0516-8 · Cited by 97 · cited 1×
“Finally, while a percent body fat of > 40% may be a better cut-off point to de fi ne obesity mortality for females [58], the clinical management of females with pre-obesity (percent body fat 30 – 34”
BackgroundBays, H. E. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.08.029 · Cited by 73 · cited 2×
“Obesity can have both metabolic and mechanical adverse consequences, including endocrine/metabolic consequences and pathogenic issues related to biomechanics [3,42 – 44].”
BackgroundSelf-citationMoran, L. J., Brinkworth, G. D., Martin, S., Wycherley, T. P., Stuckey, B., Lutze, J., Clifton, P. M., Wittert, G. A., & Noakes, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161297 · Cited by 72 · cited 1×
“…loss in females with obesity may improve metabolism (polycystic ovary syndrome) as well as improve obesity-related gynecologic and obstetric disorders; weight loss in males with obesity may increase testosterone levels when hypogonadism is due to the adiposopathic consequences of obesity [14, 15].”
BackgroundOptimal cut-off values and population means of waist circumference in different populations
Wang, Z., Ma, J., & Si, D. (2010) · Nutrition Research Reviews · doi:10.1017/s0954422410000120 · Cited by 62 · cited 3×
“Racial/ethnic differences exist in the cut-off points that correlate to an increased risk of metabolic disease [59,60].”
Background
Cited by
Lopez-Jimenez, F., Almahmeed, W., Bays, H., Cuevas, A., Di Angelantonio, E., le Roux, C. W., Sattar, N., Sun, M. C., Wittert, G., Pinto, F. J., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac187 · Cited by 362
Self-citationNadolsky, K., Garvey, W. T., Agarwal, M., Bonnecaze, A., Burguera, B., Chaplin, M. D., Griebeler, M. L., Harris, S. R., Schellinger, J. N., Simonetti, J., et al. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.07.017 · Cited by 141
Nadolsky, K., Addison, B., Agarwal, M., Almandoz, J. P., Bird, M. D., DeGeeter Chaplin, M., Garvey, W. T., & Kyle, T. K. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.03.272 · Cited by 86
Bays, H. E., Fitch, A., Christensen, S., Burridge, K., & Tondt, J. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100018 · Cited by 68
Self-citationGilbert, O., Gulati, M., Gluckman, T. J., Kittleson, M. M., Rikhi, R., Saseen, J. J., & Tchang, B. G. (2025) · JACC · doi:10.1016/j.jacc.2025.05.024 · Cited by 65
Metadata
- Authors
- Fitch, A. K., & Bays, H. E.
- Venue
- Obesity Pillars
- Publisher
- Elsevier BV
- Published
- 2022-03
- Volume
- 1
- Pages
- 100004
- ISSN
- 2667-3681 (ISSN-L)
- OpenAlex
- W4206745508
- Cited by
- 132
- References
- 40
- FWCI
- 38.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.